Clearpoint Average Payables from 2010 to 2024

CLPT Stock  USD 16.43  0.25  1.50%   
Clearpoint Neuro Average Payables yearly trend continues to be comparatively stable with very little volatility. Average Payables will likely drop to about 688.5 K in 2024. Average Payables is the average amount owed to suppliers and creditors over a specific period, reflecting Clearpoint Neuro's payment cycle and credit terms with suppliers. View All Fundamentals
 
Average Payables  
First Reported
2010-12-31
Previous Quarter
724.7 K
Current Value
688.5 K
Quarterly Volatility
921.2 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.5 M, Interest Expense of 366.7 K or Selling General Administrative of 7.5 M, as well as many indicators such as Price To Sales Ratio of 7.13, Dividend Yield of 0.0 or PTB Ratio of 8.29. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
  
Check out the analysis of Clearpoint Neuro Correlation against competitors.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Latest Clearpoint Neuro's Average Payables Growth Pattern

Below is the plot of the Average Payables of Clearpoint Neuro over the last few years. It is the average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers. Clearpoint Neuro's Average Payables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clearpoint Neuro's overall financial position and show how it may be relating to other accounts over time.
Average Payables10 Years Trend
Slightly volatile
   Average Payables   
       Timeline  

Clearpoint Average Payables Regression Statistics

Arithmetic Mean1,270,559
Geometric Mean1,049,600
Coefficient Of Variation72.50
Mean Deviation691,449
Median847,448
Standard Deviation921,192
Sample Variance848.6B
Range2.4M
R-Value(0.81)
Mean Square Error320.1B
R-Squared0.65
Significance0.0003
Slope(166,036)
Total Sum of Squares11.9T

Clearpoint Average Payables History

2024688.5 K
2023724.7 K
2018630.2 K
20171.2 M
20161.1 M
2015847.4 K

About Clearpoint Neuro Financial Statements

Clearpoint Neuro shareholders use historical fundamental indicators, such as Average Payables, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Average Payables724.7 K688.5 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.